IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,061,000 | +12.0% | 54,530 | -4.2% | 0.01% | 0.0% |
| Q4 2017 | $947,000 | -18.2% | 56,895 | -0.3% | 0.01% | -28.6% |
| Q3 2017 | $1,158,000 | +30.1% | 57,071 | +3.2% | 0.01% | +40.0% |
| Q2 2017 | $890,000 | +143.2% | 55,286 | +91.2% | 0.01% | +66.7% |
| Q1 2017 | $366,000 | +57.1% | 28,920 | +64.6% | 0.00% | +50.0% |
| Q4 2016 | $233,000 | -33.4% | 17,570 | +18.9% | 0.00% | -33.3% |
| Q3 2016 | $350,000 | -0.3% | 14,776 | +21.4% | 0.00% | 0.0% |
| Q2 2016 | $351,000 | -22.2% | 12,168 | -13.5% | 0.00% | -25.0% |
| Q1 2016 | $451,000 | -15.9% | 14,071 | +12.3% | 0.00% | -20.0% |
| Q4 2015 | $536,000 | +44.1% | 12,534 | +18.6% | 0.01% | +25.0% |
| Q3 2015 | $372,000 | -22.8% | 10,571 | +0.8% | 0.00% | -20.0% |
| Q2 2015 | $482,000 | +5.7% | 10,489 | +7.7% | 0.01% | 0.0% |
| Q1 2015 | $456,000 | +92.4% | 9,738 | +29.9% | 0.01% | +66.7% |
| Q4 2014 | $237,000 | – | 7,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |